4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-20-004351
Options or other derivatives
- General Counsel/Secretary acquired 616,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Leavitt Chase C. · General Counsel/Secretary
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-17 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +616,700 | 616,700 | D |
Loading xslF345X03/ownership.xml…